Drug
CC-11050 clinical trials
Also written CC-11050.
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2010
Keep track of what changes. Save the CC-11050 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
5 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 3
Amgen (2) · Medicines Development for Global Health (1) · The Leprosy Mission Nepal (1) · The Aurum Institute NPC (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses CC-11050 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 ReactionRecruitingPhase 2Medicines Development for Global HealthNCT07172659Written as Dovramilast
- CC-11050 Trial in Nepalese Patients With Erythema Nodosum LeprosumStatus unknownPhase 2The Leprosy Mission NepalNCT03807362Written as CC-11050
- To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedPhase 2AmgenNCT01300208Written as CC-11050
- A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With OmeprazoleCompletedPhase 1AmgenNCT04139226Written as CC-11050
- TB Host Directed TherapyStatus unknownPhase 2The Aurum Institute NPCNCT02968927Written as CC-11050
Codes
What other systems call CC-11050 · ClinicalTrials.gg INT001700
- MeSH (NLM) C000718973CC-11050One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718973 | CC-11050 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.